Article Details
Retrieved on: 2021-06-04 21:33:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Truist Securities lifted their price objective on shares of Dicerna Pharmaceuticals from $35.00 to $45.00 in a research note on Monday, April 19th.
Article found on: www.marketbeat.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here